openPR Logo
Press release

In Vitro Fertilization (IVF) Market in Russia, Brief Analysis By Top Key players Ava-Peter Clinic, MD Medical Group, and IVF Russia (The International Centre of The Reproductive Medicines) and Many Others

04-04-2019 01:37 PM CET | Health & Medicine

Press release from: Allied Market Research

In Vitro Fertilization (IVF) Market in Russia

In Vitro Fertilization (IVF) Market in Russia

The IVF market size in Russia was valued at $398 million in 2015, and is projected to reach $641 million by 2022, growing at a CAGR of 7.0% from 2016 to 2022. Non-assisted IVF cycles are projected to witness the highest growth rate from 2016 to 2022.

Fertility clinics and hospitals collectively contributed about three-fourths of the market revenue in 2014. This is attributed to their crucial role in providing technologically advanced IVF treatment to couples seeking assistance for infertility treatment.

Download Report Sample https://www.alliedmarketresearch.com/request-sample/2389

In vitro fertilization (IVF) is an assisted reproductive technology (ART) that involves extraction of eggs, sample retrieval of sperm cells, followed by manual combination of an egg and sperm in laboratory settings to form an embryo. The embryo(s) is then transferred to the womans uterus for further gestation.

The Russia IVF market is driven by increase in incidence of infertility cases, emergent trend of delayed pregnancies among women, technological advancements in IVF procedures, and rise in gamete donation. However, insufficient reimbursement policies related to IVF treatment are anticipated to impede this growth. Moreover, growth in interest of single parents and same-sex couples to experience parenthood through ART, especially IVF, is expected to present various opportunities for market development.

The fertility clinics segment accounted for the highest share of the Russia IVF end user market in 2015, owing to the availability of wide range of fertility treatments under a single roof and applicable government reimbursements. The donor egg IVF cycle type segment is anticipated to witness the highest growth rate from 2016 to 2022. However, the fresh cycle (non-donor) is projected to dominate the cycle type market.

At present, gonadotropins & gonadotropin-releasing hormones dominate the drug segment of the market, and is expected to grow at a CAGR of 6.5% during the forecast period. This is attributable to the effectiveness and safety of this drug to stimulate ovulation during an IVF procedure.

Key Findings of the Russia In Vitro Fertilization (IVF) Market:

• The fertility clinics end-user segment is anticipated to grow at the highest CAGR from 2016 to 2022 in terms of value as well as volume.
• The fresh IVF cycle (non-donor) cycle type segment generated the highest revenue in 2015, and is expected to continue its dominance in the near future.
• ICSI assisted IVF cycles dominated the Russia in vitro fertilizationmarket, and are projected to grow at a CAGR of 6.4%.
• Donor egg IVF cycle type is expected to witness the highest growth rate in terms of value as well as volume during the forecast period.

Get More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/2389

The major companies profiled in the report include Ava-Peter Clinic, MD Medical Group, and IVF Russia (The International Centre of the Reproductive Medicines).

Table Of Content

Chapter: 1 RUSSIA IVF MARKET
1.1. EUROPE IVF MARKET (REVENUE AND NUMBER OF CYCLES)
1.2. RUSSIA IVF MARKET (REVENUE AND NUMBER OF CYCLES)
1.2.1. Market size and forecast
1.2.2. Russia IVF market, by end user
1.2.2.1. Market size and forecast
1.2.2.2. Fertility clinics
1.2.2.3. Hospitals
1.2.2.4. Surgical centers
1.2.2.5. Clinical research institutes
1.2.3. Russia IVF market, by cycle type
1.2.3.1. Market size and forecast
1.2.3.2. Fresh IVF cycles (non-donor)
1.2.3.3. Thawed IVF cycles (non-donor)
1.2.3.4. Donor egg IVF cycles
1.2.4. Russia IVF market, by type
1.2.4.1. Market size and forecast
1.2.4.2. Non-ICSI IVF cycles
1.2.4.3. ICSI-assisted IVF cycles
1.2.5. Russia IVF market by pharmacological modality
1.2.5.1. Overview
1.2.5.2. Key trends
1.2.5.3. Market size and forecast
1.2.5.4. Duration of therapy
1.2.5.5. Segmentation of drugs for IVF
1.2.5.5.1. Clomiphene citrate
1.2.5.5.2. Aromatase inhibitors
1.2.5.5.3. Gonadotropins & gonadotropin-releasing hormone (GnRH)
1.2.5.5.4. Follicle-stimulating hormone (FSH)
1.2.5.5.5. Progesterone
1.2.5.5.6. Others
1.2.5.6. Mode of administration
1.2.5.6.1. Oral
1.2.5.6.2. Injectable
1.2.5.6.3. Vaginal
1.2.6. Market dynamics
1.2.6.1. Drivers
1.2.6.1.1. Rise in popularity of fertility tourism
1.2.6.1.2. Advanced IVF facilities and treatment options
1.2.6.2. Restraint
1.2.6.2.1. Inadequate reimbursement policies
1.2.7. Regulatory issues, legislations, and authorities
1.2.8. Insurance reimbursement scenario

Chapter: 2 COMPANY PROFILES
2.1. AVA-PETER CLINIC
2.1.1. Company overview
2.1.2. Company snapshot
2.1.3. Product portfolio
2.2. MD MEDICAL GROUP INVESTMENTS PLC (MD MEDICAL GROUP)
2.2.1. Company overview
2.2.2. Company snapshot
2.2.3. Operating business segments
2.2.4. Product portfolio
2.2.5. Business performance
2.2.6. Key strategic moves and developments
2.3. IVF RUSSIA (THE INTERNATIONAL CENTRE OF THE REPRODUCTIVE MEDICINES)
2.3.1. Company overview
2.3.2. Company snapshot
2.3.3. Operating business segments

Access Full Summery @ https://www.alliedmarketresearch.com/russia-in-vitro-fertilization-IVF-market

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In Vitro Fertilization (IVF) Market in Russia, Brief Analysis By Top Key players Ava-Peter Clinic, MD Medical Group, and IVF Russia (The International Centre of The Reproductive Medicines) and Many Others here

News-ID: 1688199 • Views: 646

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for IVF

How In Vitro Fertilization Market Will Dominate In Coming Years? Key Players: Mo …
The global in vitro fertilization (IVF) market size is prophesized to reach USD 36.39 billion by 2026, with a CAGR 10.1% by 2026. This is attributable to the increasing cases of infertility among people worldwide. This is more common in males than female partners. The market value was USD 16.89 billion in 2018. IVF is a fertilization process wherein sperm and eggs are retrieved as a sample and are combined
Best IVF Specialists in Pune
IVF is also known as test tube baby treatment, which has helped those couples who are unable to conceive their baby through natural process. During this procedure, female eggs are retrieved from her ovaries and are made to mix with sperms in the lab. Multiple embryos are formed during the procedure, which are transferred back into the woman’s uterus. IVF Experts in Pune are highly trained and take care of their
India IVF Treatment Market Outlook 2018
India has a large population of 1.22 Billion people and infertility in the country is rising at a rapid rate (about 30 Million couples suffer from infertility). Infertility or the inability to have children refers to a range of disorders some of which affect the male, and some the female, and contribute to childlessness in a couple. There is also something called unexplained infertility, where doctors are unable to provide
UAE IVF Treatment Market Outlook 2018
UAE has been projected as one of the upcoming IVF market meeting all international health expectations and standards in terms of quality of services provided without discrimination. It bears a potential to become a hub for promoting medical tourism keeping in mind the recent changes that have been introduced by the government, healthcare facilities that meet international standards and the well qualified doctors that are willing to serve here. The country
UK IVF Services Market
According to a new report published by Allied Market Research titled, UK IVF Services Market by End User and Cycle Type: Opportunity Analysis and Industry Forecast, 2014-2022, the UK IVF services market is estimated to reach $685.4 million by 2022, registering a CAGR of 7.7% from 2016 to 2022. The UK IVF services market is characterized by important factors such as increase in cases of infertility, delayed marriages, and parenthood decisions.
04-12-2017 | Health & Medicine
TMR
Global In Vitro Fertilization (IVF) Market
In vitro fertilization (IVF) has today emerged as one of the most preferred choices for individuals and couples with problems of infertility. This assisted reproductive method is also widely popular among single mothers and individuals from the LGBT community. Rising cases of infertility, recent innovations in IVF procedures, an emerging trend of delayed pregnancies among women, favorable reimbursement scenarios, and the surge in disposable income and health-care spending have significantly